Weekly Updates & Resources from CHUG

THE FDA AUTHORIZES BAMLANIVIMAB FOR EMERGENCY USE

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) allowing the emergency use of the unapproved product bamlanivimab as a treatment for high-risk COVID-19 adult and pediatric patients.